Andrew Schwendenman, Chief Accounting Officer of Replimune Group, Inc., filed a Form 4 on November 18, 2026, disclosing the sale of 2,148 shares of common stock on November 16, 2026, to cover tax withholding obligations arising from the vesting of Restricted Stock Units.

Key Highlights

  • Reporting person: Andrew Schwendenman, Chief Accounting Officer of Replimune Group, Inc. (NASDAQ:REPL)
  • Transaction date: November 16, 2026
  • Shares sold: 2,148 shares of common stock, disposed of (D) under transaction code S
  • Weighted average price: $21.6 per share, with individual transactions ranging from $21.59 to $21.60 per share
  • Beneficial ownership following transaction: 97,277 shares held directly
  • Purpose: Sale made solely to cover tax withholding on RSU vesting, pursuant to an irrevocable "sell to cover" provision in the award agreements

RSU Tax Withholding Sale by Replimune's Chief Accounting Officer

According to the filing, Andrew Schwendenman, serving as Chief Accounting Officer of Replimune Group, Inc., disposed of 2,148 shares of the company's common stock on November 16, 2026. The filing identifies the transaction code as S and classifies the shares as directly owned. The reported weighted average sale price was $21.6 per share.

The filing's explanation of responses states that the shares were "sold to cover tax withholding obligations in connection with the vesting of the Reporting Person's Restricted Stock Units." The filing further states the transaction "was made in accordance with the irrevocable 'sell to cover' provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person." The shares were sold in multiple transactions at prices ranging from $21.59 to $21.60 per share, and the filing notes that Schwendenman will provide per-price transaction detail upon request to the issuer, any security holder, or SEC staff.

Following the reported transaction, Schwendenman's direct beneficial ownership in Replimune Group common stock stood at 97,277 shares, according to the filing. No derivative securities transactions were reported. The Form 4 was signed by Shawn Glidden as attorney-in-fact and filed on November 18, 2026.

What Was Disclosed

The filing disclosed a single sale of 2,148 common shares by Replimune Group's Chief Accounting Officer on November 16, 2026, at a weighted average price of $21.6 per share, executed under a mandatory "sell to cover" provision tied to RSU vesting, leaving him with 97,277 shares directly owned.